Insider holders · CIK 0001013606
ENDOLOGIX INC /DE/ · ELGX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Camber Capital Management LP10% Owner | — | 9,300,000 | 9,300,000 | Oct 30, 2018 · 11:46 am EDT | Form 4 |
| John D McDermottDirector | 879,423 | — | 879,423 | May 30, 2018 · 6:51 pm EDT | Form 4 |
| John OnopchenkoCEO and Director | 661,037 | — | 661,037 | Jan 2, 2019 · 8:09 pm EST | Form 4 |
| Vaseem MahboobChief Financial Officer | 616,927 | — | 616,927 | Jan 2, 2019 · 9:01 pm EST | Form 4 |
| Matthew ThompsonChief Medical Officer | 542,319 | — | 542,319 | Feb 1, 2019 · 4:03 pm EST | Form 4 |
| Christopher G. ChavezDirector | 378,346 | 65,640 | 443,986 | May 30, 2018 · 7:39 pm EDT | Form 4/A |
| Dan LemaitreDirector | 331,065 | — | 331,065 | Jan 2, 2019 · 8:02 pm EST | Form 4 |
| Robert D MitchellPresident | 316,886 | — | 316,886 | Jun 20, 2017 · 10:50 am EDT | Form 4 |
| Guido J NeelsDirector | 205,089 | 38,055 | 243,144 | Jan 3, 2019 · 5:49 pm EST | Form 4 |
| Michael V. ChobotovChief Technology Officer | 203,269 | — | 203,269 | Sep 26, 2016 · 11:03 am EDT | Form 4/A |
| III Thomas F ZentyDirector | 190,283 | — | 190,283 | Jan 2, 2019 · 7:57 pm EST | Form 4 |
| Thomas WilderDirector | 171,947 | — | 171,947 | Jan 2, 2019 · 8:00 pm EST | Form 4 |
| Gregory D WallerDirector | 171,437 | — | 171,437 | Jan 2, 2019 · 8:23 pm EST | Form 4 |
| Leslie V NorwalkDirector | 164,378 | — | 164,378 | Jan 2, 2019 · 8:05 pm EST | Form 4 |
| Joseph A. DeJohnGeneral Manager, Asia & Pac | 153,471 | — | 153,471 | Jul 11, 2016 · 10:54 am EDT | Form 4 |
| Shari L O'QuinnVP, Clinical & Regulatory | 94,356 | — | 94,356 | Jun 6, 2017 · 9:55 am EDT | Form 4 |
| Todd AbrahamVP of Operations | 86,821 | — | 86,821 | Nov 17, 2015 · 11:15 am EST | Form 4 |
| Janet Mary FaulsVP Regulatory Affairs | 82,492 | — | 82,492 | Jun 1, 2015 · 10:28 am EDT | Form 4 |
| David M. JenningsVP-Human Resources | 50,281 | — | 50,281 | Jun 2, 2016 · 4:00 pm EDT | Form 4 |
| Laura NagelVP, Quality | 48,860 | — | 48,860 | Mar 15, 2018 · 4:23 pm EDT | Form 4 |
| Jeremy B. HaydenGeneral Counsel | 47,506 | — | 47,506 | Apr 23, 2018 · 5:06 pm EDT | Form 3 |
| Charles Steele LoveVP-Clinical Affairs | 45,037 | — | 45,037 | Jan 28, 2016 · 1:30 pm EST | Form 4 |
| Amanda L. DePalmaVP, Global Marketing | 43,772 | — | 43,772 | Jun 2, 2016 · 3:59 pm EDT | Form 4 |
| Cecile FerracciGeneral Manager, Europe | 40,706 | — | 40,706 | Feb 17, 2016 · 4:18 pm EST | Form 4 |
| James Edward MachekVP-Research & Development | 38,286 | — | 38,286 | Jun 2, 2016 · 4:02 pm EDT | Form 4 |
| Jose A. LimaVP-Quality | 37,884 | — | 37,884 | Aug 22, 2016 · 4:28 pm EDT | Form 4 |
| Shelley B Thunenrelationship not stated | 17,143 | — | 17,143 | Oct 21, 2015 · 2:42 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.